Results 141 to 150 of about 2,828 (161)
Some of the next articles are maybe not open access.

Diosmetin: An Anti‐Leukemic Flavonoid Targeting the Estrogen Receptor β

The FASEB Journal, 2016
Acute myeloid leukemia (AML) is an aggressive hematological malignancy resulting from the accumulation of immature myeloid cells in the peripheral blood and bone marrow. It is associated with poor prognosis, especially in older patients where the 2‐year survival rate is approximately 10%.
Sarah G. Rota   +2 more
openaire   +1 more source

Investigating In silico and In vitro Therapeutic Potential of Diosmetin as the Anti-Parkinson Agent

Protein & Peptide Letters
Aim: This study aimed to investigate how diosmetin interacts with seven target receptors associated with oxidative stress (OS) and validate its antioxidant properties for the potential management of Parkinson’s disease (PD). Background: In PD, the degeneration of dopaminergic cells is strongly influenced by OS. This stressor is intricately connected
Krishna Kumar, Varshney   +2 more
openaire   +2 more sources

Diosmetin Promotes Early Embryonic Development in Pigs by Alleviating Oxidative Stress

Molecular Reproduction and Development
ABSTRACTDiosmetin (DIOS), a natural flavonoid monomer derived from lemons and present in various plants such as spearmint and spider moss, exhibits antioxidant, anti‐inflammatory, and antiaging properties. Nonetheless, its impact on early embryonic development in pigs remains unexplored.
Jia-Jun, Ren   +6 more
openaire   +2 more sources

Diosmetin attenuates fibromyalgia-like symptoms in a reserpine-induced model in mice

Inflammopharmacology
Fibromyalgia is a potentially disabling idiopathic disease characterized by widespread chronic pain associated with comorbidities such as fatigue, anxiety, and depression. Current therapeutic approaches present adverse effects that limit adherence to therapy.
Lara Panazzolo Marquezin   +6 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy